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9 Fluid Balance andManagement and theCritically Ill Woman
Nick Rowe*
Midwives are often required to administer fluid replacement therapy in different
situations such as shock and pre-eclampsia. Therefore, an understanding of the
need for appropriate fluid replacement and the actual intended action of the fluid
is crucial. Inappropriate fluid replacement could have the potential to compromise
the woman’s condition and lead to a clinical deterioration which would need 
further intensive management. This chapter will explain the physiology of fluid
replacement and discuss the benefits and possible detrimental effects each fluid
could cause.
Assumed prior knowledge
l Physiology of the cardiovascular and renal systems
l Physiological changes in the cardiovascular and renal system during pregnancy
Introduction
To maintain a state of physiological wellbeing, regular quantities of water, 
electrolytes and energy are required. A disproportionate or reduced fluid intake
or loss can lead to serious physiological adjustments, significant morbidity 
and even mortality. A normal fluid balance should enable the body to maintain
homeostasis. This chapter explores normal fluid balance and details of the fluids
required to maintain this equilibrium.
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The process of normal fluid balance
The cardiovascular system is vital in its role for the distribution and absorption 
of gases, nutrients and metabolites, throughout the body. The normal passage 
of circulatory fluids is shown in Fig. 9.1. The passage between the arterial and
venous systems is regulated by tube-like endothelial capillaries. The transfer 
of gases, nutrients and metabolites takes place at a cellular level. Oxygen, for
example, carried by erythrocytes (red blood cells) is transported through the 
capillary wall to interact with tissue cells (Fig. 9.2). The medium through which
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Figure 9.1 Normal passage of circulatory fluids.
Figure 9.2 Transfer of fluids between the tissues and the arterial and venous systems.
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the cells pass is the interstitium. The interstitium is a fibrous tissue and binds 
the capillary with the surrounding tissues. The fluid present in the interstitium
allows the passage of solutes to and from the tissue cells, thus allowing the 
supply of gases, nutrients and hormones and the return of unused or waste 
products.
The fluid volume contained in the body is referred to as the total body water.
This is divided between three compartments, with 25% in the vascular space, 
8% in the interstitial space and 67% within the intracellular compartment. In a 
70 kg male, the total body water is approximately 60% of the total body weight
(around 42 L). In females, due to increased fat levels, this figure may be reduced to
50% (around 35 L).
Surplus tissue fluid is collected by the lymphatic system at the lymphatic 
capillary bed. Regulated by lymph nodes, the fluid is returned to the venous 
system, with the upper right body quadrant draining via the right lymphatic duct
and the remainder via the thoracic duct.
The passage of fluid between the intracellular fluid (ICF) space and the 
extracellular fluid (ECF) space, which includes both plasma and interstitial fluid,
is governed by osmosis. As both ICF and ECF are isotonic, an osmotic equilibrium
exists at the cell membrane. ICF has potassium as its principle cat ion and is sensi-
tive to changes in ECF sodium concentrations. A raise in serum or ECF sodium
levels will cause water to pass from the ICF to the ECF. The reverse is also seen
when ECF sodium concentrations are reduced. Albumin and a higher proportion
of water with its dissolved oxygen are forced from the arterial end of the capillary
by hydrostatic pressure, into the interstitium. The concentration of albumin
remaining in the plasma is increased due to the water displacement, so increasing
the colloid oncotic pressure. At the venous end of the capillary, the reduced blood
pressure and raised oncotic pressure draw water containing carbon dioxide and
metabolites back into the vasculature for transfer to the lungs, etc.
The extracellular space is regulated by both its tonicity and volume. Tonicity is
governed by osmoreceptors in the brain, which serve to stimulate or suppress
thirst, and to regulate water output. The smooth muscle that surrounds blood
vessels controls either constriction (sympathetic nerve stimulation) or dilatation
(parasympathetic nerve stimulation). An equal stimulus from both sympathetic
and parasympathetic systems produces normal vascular tone. Reduced systemic
arterial pressure in the renal system can lead to sodium and water retention in 
the kidney. Water retention itself can result in hyponatraemia (a sodium level of 
< 135 mmol/L) and, as previously mentioned, can result in a migration of water
from the ECF to the ICF. Whilst this would impact upon the volume of the ECF,
the total sodium level would not decrease in ratio to the fluid distribution, as 
electrolytes are unable to pass across the cell membrane. Other impacting factors
relating to the ECF space are fluid intake (either oral or infusion therapy) and
evaporation due to irregular thermoregulation and gastrointestinal conditions
such as vomiting and diarrhoea. An imbalance of circulating fluid as either hypo-
or hypervolaemia, will also impact on the normal process of fluid balance. This
natural fluid balance may also be greatly disrupted by normal physiological
changes in pregnancy related to conditions such as severe hypertensive disorders
of pregnancy and postpartum haemorrhage.
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Effective fluid balance in critically ill women
An effective fluid balance in any situation has but one aim; to maintain a normal
balance that takes into account both the previous events and the current condition
of the patient, and pre-empts foreseeable occurrences. Haemodynamics seen 
during pregnancy, whilst differing greatly from the baseline values, maintain a
function that serves the needs of both mother and baby. In classifying a woman 
as being ‘critically ill’, we are therefore looking to have observed signs and 
symptoms that differ greatly from those we might normally expect to see, and 
can determine them to be an actual or imminent threat.
The physiology of fluid administration will show an initial expansion of the
intravascular compartment. The subsequent passage across the capillary structure
decrees the extent and duration of effect of the infusion. This differentiates
between crystalloid and colloid solutions. Conditions that combine a decreased
blood flow and oxygen transfer to the tissues that result in cellular hypoxia and
potential organ dysfunction are represented as shock, which is explained at a
greater depth in Chapter 8.
The most common pregnancy-related condition that affects fluid balance is 
pre-eclampsia. In respect of fluid management, the extremes that commonly
guide treatment regimes are, on the one hand, pulmonary oedema versus renal
failure on the other. Pearson (1992) argues that the woman with severe pre-
eclampsia is at high risk of pulmonary oedema and as such should be fluid
restricted with early diuretic therapy. Indeed, with women with a central venous
pressure (CVP) of ≥ 4 mmHg, additional crystalloid infusion can raise the CVP to
≥ 10 mmHg, thus precipitating pulmonary oedema relating to the free passage of
crystalloids between the intra- and extravascular spaces (Robson 1999).
However, the treatment of pre-eclamptic hypertension with hydralazine with-
out a preload fluid dose can cause hypotension, fetal distress and oliguria (Magee
et al. 2003). Reduced systemic arterial pressure in the renal system can lead to
sodium and water retention in the kidney. This will cause a concentration of 
the urine output, seen as a darkening in colour and a thickened consistency; 
however this does not necessarily indicate renal failure, which affects approx-
imately 1.5% of women in severe pre-eclampsia. Dehydration that manifests 
as thirst, however, indicates a depletion of 1 L or more and should be managed.
Oral fluid intake will rarely result in toxicity and can be passed through the 
body; women can therefore be encouraged to drink at regular intervals. As such,
maintenance fluids can be given as crystalloid fluids. In women with a urine 
output of < 100 ml/4 h, CVP can be measured. Readings of < 4 mmHg can be
treated with 400 ml of 5% albumin. Careful challenges of colloid fluids, which
remain in the intravascular space due to their higher molecular weight, will 
maintain colloid oncotic pressure – as opposed to crystalloids that are associated
with a postpartum fall.
Pre-eclampsia can be considered to be a condition that illustrates a degree of
distributive/vasogenic shock. Despite a relatively normal cardiac function and
blood volume, the irregular distribution of blood can result in poor oxygenation
of the tissues. Other shock-related disorders that can affect the distribution of
body fluids are:
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l Septic shock. As a result of the cardiac output and vasodilatation being
depressed, a physiological attempt is made to direct the blood flow to critical
organs at the expense of the pulmonary and renal systems. This results in an
increased permeability of the capillaries, allowing water and large proteins
such as albumin to migrate to the interstitium resulting in loss of proteins,
hypovolaemia and interstitial oedema.
l Anaphylactic shock. The release of histamine, serotonin and other chemical
mediators following the stimulation of the antibody–antigen complex, activates
the cells of the immune system (such as mast cells and basophils) which causes
vasodilatation and capillary permeability. This allows fluids to migrate from
the intervascular compartment to the interstitium. The result is a fall in blood
pressure and hypovolaemia resulting in tissue hypoxia.
l Hypovolaemic shock. This occurs when fluid leaves the cardiovascular space
either to an internal space (as seen in distributive shock, burns or internal
haemorrhage) or to external loss.
Fluid management
When considering the management of fluids in the critically ill woman, it is imper-
ative not to lose sight of the fundamentals of fluid balance. The fluid volume 
contained in the body (total body water) is divided between three compartments,
with 25% in the vascular space, 8% in the interstitial space and 67% within the
intracellular compartment.
The composition of ECF and ICF is shown in Table 9.1.
Table 9.1 Composition of extracellular and intracellular fluids.
Intracellular fluid (28 L) Extracellular fluid (14 L)
Sodium 14 mmol/L Sodium 150 mmol/L
Potassium 150 mmol/L Potassium 4 mmol/L
Bicarbonate 10 mmol/L Bicarbonate 27 mmol/L
Protein 74 mmol/L Protein Plasma = 16 mmol/L
ISF = 2 mmol/L
ISF, interstitial fluid.
By looking at routine throughput of fluids and the metabolism of electrolytes
(Table 9.2), a maintenance baseline of daily requirements can be identified.
Intravenous fluids are distributed in differing ways between the intracellular,
interstitial and plasma compartments (Table 9.3) and so the choice of fluid type is
of vital importance.
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From Table 9.3 we can see that a normal saline solution, whilst good for the
maintenance of water and electrolyte homeostasis, will only be able to compensate
for a blood volume loss of up to 20%. A colloid however, with a high molecular
weight of > 10 000 Da, will stay entirely in the intravascular space. A combination
therapy will therefore allow the crystalloid to provide tissue hydration, whilst a
colloid infusion will hydrate the vasculature. It is important to note that simply
infusing fluids will not correct electrolyte or component imbalance. Regular 
laboratory testing will show deficiencies or accumulations that result from the
woman’s condition and their response to fluid therapy. For example, during 
massive fluid resuscitation, full blood count tests will ensure that the woman’s
blood components are not simply diluted to an anaemic degree, simply for the
sake of restoring volume. Any fluid infused must be able to perform its required
function; that is, the distribution and absorption of gases, nutrients and meta-
bolites throughout the body.
Principles of fluid management
Accurate fluid balance recording
This should include all oral/intravenous and otherwise introduced fluids.
Balanced against these should be all excreted fluids such as urine output,
vomit/diarrhoea and haemorrhage. It is best if all factors that relate to a patient’s
172 Critical Care in Childbearing for Midwives
Table 9.2 Example of daily input versus output.
Input H2O 2500 ml/day Output H2O 2500 ml/day
Fluids 1400 ml Urine 1500 ml
Food 750 ml Skin 500 ml
Metabolism 350 ml Lungs 400 ml
Faeces 100 ml
Sodium 50–90 mmol
Potassium 50–90 mmol
Table 9.3 Distribution of fluid between the intracellular, interstitial and plasma compartments.
Intracellular Interstitial Plasma
Isotonic saline 0% 80% 20%
Water (dextrose solution) 67% 25% 8%
Colloids 0% 0% 100%
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fluid balance are recorded on a single 24-hour sheet. In the critical care scenario,
this should ideally be a component of their daily care record, which combines
observations with treatment regimes, along with an area for staff to document
their own comments. In this way, we reduce the possibility of events either being
passed over or taken out of context. This should be implemented for any patient
whose condition gives rise for concern.
Maintenance fluids
If a patient is able to safely drink fluids, they should be encouraged to do so. Any
dehydration that manifests as thirst indicates a depletion of > 1 L. A background
infusion of crystalloid fluid such as Hartmann’s solution or 0.9% sodium chloride
at 90 ml/h will offset the normal excretion of water by the body. In cases of vomit-
ing or fasting, not only does the patient lose fluid but she is also prevented from
any normal maintenance. During fasting a woman can lose 420 ml water in 4 hours,
rising to 1260 ml in 12 hours. Sodium and potassium loss under the same con-
ditions are equal at 12 mmol at 4 hours, rising to 35 mmol at 12 hours. In addition,
stress may also induce the release of antidiuretic hormone (ADH), aldosterone
and cortisol. This can then lead to water and sodium retention with the loss of
potassium. Thus, if fluid balances are compromised for more than 24 hours, the
potassium levels of the patient should be considered.
Possible invasive central venous monitoring
In cases of proven oliguria (< 0.5 ml/kg/h) or undue haemorrhage, the insertion
of central venous monitoring should be considered. A low CVP, often indicative
of left atrial filling pressures, could be indicative of a hypovolaemic state. However,
when the reading rises above 6 cmH2O, the filling pressures are often under-
estimated and there is an increased risk of pulmonary oedema. A raised CVP in 
isolation of supporting tests proves little in regard to fluid status but may be a 
precursor to fluid overload or myocardial dysfunction. As such, the insertion of a
pulmonary artery catheter can be considered. In underloaded patients, the CVP
will fall off soon after volume loading, despite a temporary rise being seen.
The risks of insertion should, however, be taken into account. Coagulopathy
may cause bleeding and be impossible to control. Poor oxygenation or lung 
disease may further deteriorate with accidental lung damage. The potential for
sepsis is also increased with the introduction of invasive catheters. Unless there is
expertise available in both the insertion and management of catheters, and the
interpretation of results, central vein cannulation should not be attempted. In
cases of severe refractory hypertension where drugs such as nitroglycerine or
nitroprusside are used, invasive monitoring in an intensive care unit is required.
A set protocol should be available for the implementation of invasive monitoring.
Selective colloid expansion
In cases of confirmed low blood pressures or low CVP readings, fluid challenges
of 200–300 ml boluses of colloid can be administered. Colloid and plasma 
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substitutes contain high molecular weight molecules (> 10 000 Da), together with
electrolytes. The size of the molecules prevents passage through normal capillary
membranes and, as a result, they remain in the intravascular space. The efficiency
of colloids in volume replacement is, however, reduced in cases where damage 
to the capillary membrane has occurred (Vincent 2000). In pre-eclampsia, the
combination of controlled vasodilatation (i.e. using hydralazine) with limited 
colloid loading can improve cardiac function whilst reducing vascular resistance.
Whilst fluid overload is definitely to be avoided in light of the potential for the
development of pulmonary oedema, limited fluid challenges prior to vasodilata-
tion are imperative to prevent a sudden hypotensive crisis. In order to optimise
intravascular volume, additional volume can be added and/or agents to cause
vasoconstriction of the vessels can be used.
Any fluid administration should be managed with a specific end point in mind.
To that end, fluids must be flexibly titrated with constant reference to the principle
aims of administration and to the emerging physiological effects observed
through measurements taken from the woman. Indiscriminate loading of fluids
has in the past been the cause of fluid overload and ineffectual treatment and,
hence, a move to severely restrict fluid therapy for fear of adverse outcome. Adult
respiratory distress syndrome resulting from pulmonary oedema is second only
to cerebral haemorrhage as the immediate cause of death in women with pregnancy-
induced hypertensive disorders (Lewis, 2004).
Types of fluid
Accurate fluid selection must be made based on the expected function of the fluid,
for example to replace electrolytes or to replenish volume. Fluids to be used con-
sist of three categories: crystalloids, colloids and blood products.
Crystalloids
A large number of the crystalloid fluids are isotonic, which means that an equal
solute concentration exists inside and outside the cell, encouraging the cell to stay
the same size. Fluids found within this category include:
l Normal saline (0.9% sodium chloride in water): 154 mmol/L sodium and 
154 mmol/L chloride.
l Ringer’s lactate: 147 mmol/L sodium, 156 mmol/L chloride, 4 mmol/L 
potassium and 2.2 mmol/L calcium.
l Hartmann’s solution: 131 mmol/L sodium, 111 mmol/L chloride, 5 mmol/L
potassium, 2 mmol/L calcium and 29 mmol/L bicarbonate (lactate).
l Glucose 4%/NaCl 0.18%: 30 mmol/L sodium, 30 mmo/L potassium and 
40 g/L glucose (164 kcal/L).
l Glucose 5%: 50 g/L glucose (205 kcal/L).
One significantly different fluid in this category is glucose 10% (100 g/L glucose
(410 kcal/L)) which is considered hypertonic. Here, the solution on one side of the
cell membrane has a solute concentration greater than on the opposite side. Care
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should therefore be taken with glucose (dextrose) solutions as the glucose is
metabolised, leaving water. This quickly balances through the ECF and ICF
spaces and can cause hyponatraemia and cellular oedema.
Normal saline can cause hypernatraemia and hyperchloraemic acidosis if given
in excess (Gutteridge 2004).
Synthetic colloids
Synthetic colloids are used solely to expand the plasma volume as they have no
oxygen capacity or clotting functions. They may be divided into three groups.
Hydroxyethyl starch (HES)
HES solutions are derived from a modified vegetable starch dissolved in 0.9%
normal saline. This is similar to the glycogen found in liver and muscle, resulting
in a reduced potential for immunological reactions. The different ratios of
hydroxyethyl groups to glucose molecules within the starch will dictate how long
the HES is maintained in the circulatory system. Available as 6% and 10% 
solutions, the former will expand the plasma volume by 500 ml with a 500 ml 
infusion, whereas the 10% solution acts similarly to 20% albumin in that 500 ml
will cause an expansion of 750 ml volume. The difference in types available
reflects the ‘degree of substitution’ of the hydroxyethyl groups to glucose
molecules and their subsequent duration, with HES remaining up to four times
longer in the system.
The molecular weight also covers a wide range (10–2000 kDa) compared to
albumin (69 kDa). The amount of leakage through the capillaries is therefore
much reduced, thus allowing HES solutions to remain longer in the vascular 
compartment. HES is eliminated via the kidney with molecules > 70 kDa being
broken down by serum amylase. Again, the higher amount of HES groups 
present, the longer it takes for degradation to occur and hence there is a longer
duration of effect.
Gelatins
This group of colloids derive from bovine proteins made soluble in 0.9% normal
saline. Whilst molecular size varies, it tends to be approximately 30 kDa. Due to
this relatively small size, gelatin molecules are not readily retained in the vascula-
ture, leaking both into the interstitium and through the renal capillary system into
the urine. As such, gelatines do not maintain their expansion properties for more
than 3 hours. They are therefore useful for short-term expansion (e.g. to counteract
the hypotension caused by spinal anaesthesia) but require long-term infusion for
conditions such as sepsis. This sustained treatment may lead to a sodium buildup
in women who have renal or hepatic impairment.
Dextrans
Dextrans are naturally occurring glucose polymers made by leucosoic bacteria.
Simpler in structure than the hydroxyethyl groups, the molecular size is varied,
so regulating its duration within the vasculature. Dissolved in 0.9% normal saline
or 5% dextrose, dextrans are available in two molecular weights. Dextran 40 
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(low molecular weight) expands the blood by 150% of the infused volume in a
similar manner to 10% HES, but will only remain active for 6–8 hours. The higher 
molecular weight dextran 70 expands the blood by only 100% of the infused 
volume, but has approximately 18 hours effective duration. A recognised 
chemical effect of dextran is the increased plasma viscosity seen during infusion.
Whilst this definitely interferes with blood clotting functions, it is used occasion-
ally during surgery to reduce the incidence of deep vein thrombosis. There is also
an acknowledged incidence of anaphylaxis with the higher molecular weight
dextrans.
Blood and blood products
In cases of significant haemorrhage, whole blood is an ideal choice due to it hav-
ing the capacity to carry oxygen and the presence of clotting factors. Fresh blood
is preferable to stored blood as, in time, stored blood breaks down, decreasing the
concentrations of platelets and clotting factors. As a result of this breakdown, a
rise in potassium, ammonium and cell debris is to be seen.
A cross-match and typing between the recipient and donor unit must be 
undertaken prior to transfusion. An initial infusion rate of 4 ml/kg/h should be
used, unless a severe deficit is present, in which case the blood should be given as
rapidly as possible. In cases where renal/cardiac disease or an acknowledged
fluid overload is present, the infusion rate should be slowed to 1 ml/kg/h. One
unit of packed red cells can be expected to raise the haematocrit level by approx-
imately 3%. Targets for infusion should be set to reach a required haematocrit
level without exceeding it. Except in extreme emergency, blood should be infused
through both an infusion-warming device and a blood filtration system. The
blood should not exceed 42°C and any units should be infused within a 4-hour
period to prevent bacterial buildup. The woman should be carefully monitored
for signs of transfusion reaction and/or fluid overload. If fresh frozen plasma is
required, to correct coagulation deficiencies, it should be pre-thawed at room
temperature or using a controlled method over 30 minutes.
Albumin
Albumin is naturally found in the body evenly divided with one-third found in
the skin, one-third in the vasculature and one-third in the body tissues. Approx-
imately 5% of the blood albumin transfers through the capillary per hour to the
tissues (transcapillary escape rate). This acts as a buffer to the blood’s oncotic
pressure, so regulating its ability to attract water. The resulting effect is an even
hydration of blood and tissues.
Albumin can be considered for use for the following conditions: hypoalbu-
minaemia, resuscitation in acute hypovolaemia and hypovolaemia occurring
after the acute phase of critical illness. Available as 4.5% or 20%, the albumin is
dissolved in saline and acts by drawing water from the interstitium back into the
vasculature. Of the two concentrations, 100 ml of the 20% solution has the equiva-
lent effect of 300 ml of the 4.5% solution, expanding to three times its volume in
infusion. The molecular size of albumin is 69 kDa. This plays an important role in
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women suffering from oedema or sodium elimination conditions, as albumin 
levels affect the colloid oncotic pressure and thus the transfer of water to and from
the interstitium with its dissolved gasses and metabolites. In cases of capillary
leakage, the amount of colloid and water in the interstitium increases the distance
between the capillary and the cells, thus causing reduced oxygen transfer between
the two structures and resulting in hypoxia. In cases where the oedema is caused
by sepsis, it is vital to address the cause in order to prevent the return of fluids
from the interstitium and the subsequent restoration of normal gas exchange
becoming a temporary state (Allison & Lobo 2000).
Diuretic usage
As denoted by the phrase ‘fluid balance’, there is a necessary correlation between
administered or present fluids and those eliminated from the body. Concerns
regarding fluid overload, and resulting pulmonary oedema, and pre-renal oliguria
often result in the use of diuretic drugs to increase urine formation and output.
The use of loop diuretics such as frusemide (furosemide) can promote diuresis by
reducing the intravascular water and increasing the colloid oncotic pressure. This
encourages water to be drawn from the interstitial space, back into the vascula-
ture. In oliguria, it is important that the patient is fluid loaded (and still oliguric)
prior to the administration of diuretics. Sodium reabsorbtion is inhibited in the
loop of Henle in the medulla, enhancing the renal tubular oxygen balance, and
diuresis often occurs despite renal impairment. Mechanically, this can help flush
the renal tubules of any necrotic debris.
In cases of pulmonary oedema that result in adult respiratory distress syndrome,
fluid restriction and diuretic administration are an advocated course of action.
However, for critically ill pregnant women who become potentially oliguric, it is
important that the cause (such as hypovolaemia) is treated or excluded prior to
the use of diuretic drugs.
Summary
l Normal values in physiological measurements must be established as appro-
priate to the woman’s condition.
l A normal balance should be sought, that takes into account both the previous
events and the current condition of the woman, and pre-empts foreseeable
occurrences.
l Fluids and treatments should be carefully administered with clearly defined
end objectives. These should be determined by a multispeciality approach and
laid out in policy.
l Fluids have individual properties and are not simply crystalloid or colloid.
Choose with an aim in mind.
l Constant reassessment of the woman’s condition must be undertaken to avoid
potential harm.
l Expert help should be sought prior to implementing any stage of treatment.
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